James F. Fries

Q: What Schools Are Affiliated With James F. Fries

James F. Fries is affiliated with the following schools: Stanford University, University of California, San Francisco

James F. Fries's AcademicInfluence.com Rankings

James F. Fries

Philosophy

#2110

World Rank

#3677

Historical Rank

#791

USA Rank

Logic

#441

World Rank

#836

Historical Rank

#175

USA Rank

philosophy Degrees

Download Badge

Philosophy

James F. Fries's Degrees

Doctorate Medicine University of California, San Francisco

Why Is James F. Fries Influential?

(Suggest an Edit or Addition)

According to Wikipedia, James Franklin Fries was an American rheumatologist and author.

(See a Problem?)

James F. Fries's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. (1988) (20489)
The 1982 revised criteria for the classification of systemic lupus erythematosus. (1982) (14503)
Measurement of patient outcome in arthritis. (1980) (4328)
The Patient-Reported Outcomes Measurement Information System (PROMIS) developed and tested its first wave of adult self-reported health outcome item banks: 2005-2008. (2010) (3090)
Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. (1980) (3058)
Aging, natural death, and the compression of morbidity. (1980) (2633)
Osteoarthritis: New Insights. Part 1: The Disease and Its Risk Factors (2000) (2404)
The Patient-Reported Outcomes Measurement Information System (PROMIS): Progress of an NIH Roadmap Cooperative Group During its First Two Years (2007) (2177)
The American College of Rheumatology 1990 criteria for the classification of Wegener's granulomatosis. (2010) (1862)
The dimensions of health outcomes: the health assessment questionnaire, disability and pain scales. (1982) (1328)
Pathologic observations in systemic sclerosis (scleroderma). A study of fifty-eight autopsy cases and fifty-eight matched controls. (1969) (1033)
The mortality of rheumatoid arthritis. (1994) (885)
Measurement of health status in children with juvenile rheumatoid arthritis. (1994) (790)
The Stanford Health Assessment Questionnaire: a review of its history, issues, progress, and documentation. (2003) (747)
The Health Assessment Questionnaire (HAQ). (2005) (676)
Aging, health risks, and cumulative disability. (1998) (666)
The Stanford Health Assessment Questionnaire: Dimensions and Practical Applications (2003) (665)
The American College of Rheumatology 1990 criteria for the classification of vasculitis. Introduction. (2010) (621)
Clinical history as a screening test for ankylosing spondylitis. (1977) (618)
The American College of Rheumatology 1990 criteria for the classification of vasculitis. Summary. (2010) (569)
Survival, prognosis, and causes of death in rheumatoid arthritis. (1986) (463)
Gastrointestinal tract complications of nonsteroidal anti-inflammatory drug treatment in rheumatoid arthritis. A prospective observational cohort study. (1996) (429)
Reducing health care costs by reducing the need and demand for medical services. The Health Project Consortium. (1993) (422)
Evaluation of a preliminary physical function item bank supported the expected advantages of the Patient-Reported Outcomes Measurement Information System (PROMIS). (2008) (389)
The health assessment questionnaire 1992: status and review. (1992) (380)
Radiographic assessment of progression in osteoarthritis. (1987) (380)
A multicenter study of outcome in systemic lupus erythematosus. I. Entry variables as predictors of prognosis. (1982) (380)
Toward an epidemiology of gastropathy associated with nonsteroidal antiinflammatory drug use. (1989) (373)
The promise of PROMIS: using item response theory to improve assessment of patient-reported outcomes. (2005) (366)
Nonsteroidal anti-inflammatory drug-associated gastropathy: incidence and risk factor models. (1991) (353)
Measuring and Monitoring Success in Compressing Morbidity (2003) (348)
The compression of morbidity: near or far? (1989) (341)
Long-distance running, bone density, and osteoarthritis. (1986) (325)
A multicenter study of outcome in systemic lupus erythematosus. II. Causes of death. (1982) (319)
The development of disability in rheumatoid arthritis. (1986) (318)
The clinical value of the Stanford Health Assessment Questionnaire Functional Disability Index in patients with rheumatoid arthritis. (1988) (292)
Do Workplace Health Promotion (Wellness) Programs Work? (2014) (285)
PROMIS measures of pain, fatigue, negative affect, physical function, and social function demonstrated clinical validity across a range of chronic conditions. (2016) (281)
Reduced disability and mortality among aging runners: a 21-year longitudinal study. (2008) (276)
Antigen microarray profiling of autoantibodies in rheumatoid arthritis. (2005) (267)
Midlife body mass index and hospitalization and mortality in older age. (2006) (264)
Striking prevalence of ankylosing spondylitis in "healthy" w27 positive males and females. (1975) (263)
Hydroxychloroquine and risk of diabetes in patients with rheumatoid arthritis. (2007) (262)
The PROMIS Physical Function item bank was calibrated to a standardized metric and shown to improve measurement efficiency. (2014) (259)
The compression of morbidity. (1983) (259)
The health care costs of smoking. (1998) (258)
Compression of Morbidity 1980–2011: A Focused Review of Paradigms and Progress (2011) (251)
The American College of Rheumatology 1990 criteria for the classification of vasculitis. Patients and methods. (2010) (250)
The American College of Rheumatology 1990 criteria for the classification of hypersensitivity vasculitis. (2010) (246)
Lifestyle habits and compression of morbidity. (2002) (227)
Reduction in long-term disability in patients with rheumatoid arthritis by disease-modifying antirheumatic drug-based treatment strategies. (1996) (218)
Progress in Assessing Physical Function in Arthritis: PROMIS Short Forms and Computerized Adaptive Testing (2009) (214)
Risk factors for physical disability in an aging cohort: the NHANES I Epidemiologic Followup Study. (1993) (200)
The risk of osteoarthritis with running and aging: a 5-year longitudinal study. (1993) (192)
NSAID gastropathy: the second most deadly rheumatic disease? Epidemiology and risk appraisal. (1991) (189)
The compression of morbidity. 1983. (1983) (179)
The relative toxicity of disease-modifying antirheumatic drugs. (1993) (174)
Assessment of radiologic progression in rheumatoid arthritis. A randomized, controlled trial. (1986) (167)
A multicenter study of annual health service utilization and costs in rheumatoid arthritis. (1986) (164)
Safety of meloxicam: a global analysis of clinical trials. (1996) (162)
Toward an understanding of patient outcome measurement. (1983) (161)
Long-Term Randomized Controlled Trials of Tailored-Print and Small-Group Arthritis Self-Management Interventions (2004) (156)
Reevaluating the therapeutic approach to rheumatoid arthritis: the "sawtooth" strategy. (1990) (154)
Validity of PROMIS physical function measured in diverse clinical samples. (2016) (153)
Improved responsiveness and reduced sample size requirements of PROMIS physical function scales with item response theory (2011) (152)
Fractures in rheumatoid arthritis: an evaluation of associated risk factors. (1993) (148)
The relative toxicity of nonsteroidal antiinflammatory drugs. (2010) (148)
Predictors of fractures in early rheumatoid arthritis. (1991) (147)
Long distance running and knee osteoarthritis. A prospective study. (2008) (146)
Proteomic analysis of secreted proteins in early rheumatoid arthritis: anti-citrulline autoreactivity is associated with up regulation of proinflammatory cytokines (2006) (143)
Progression of functional disability in patients with rheumatoid arthritis. Associations with rheumatology subspecialty care. (1993) (143)
Running and the Development of Disability with Age (1994) (142)
Beyond health promotion: reducing need and demand for medical care. (1998) (139)
Item Response Theory, Computerized Adaptive Testing, and PROMIS: Assessment of Physical Function (2014) (139)
Toxicity profiles of disease modifying antirheumatic drugs in rheumatoid arthritis. (1991) (138)
Patient education in arthritis: randomized controlled trial of a mail-delivered program. (1997) (137)
Validation of the PROMIS physical function measures in a diverse US population-based cohort of cancer patients (2015) (136)
Two-year results of a randomized controlled trial of a health promotion program in a retiree population: the Bank of America Study. (1993) (136)
The relationship of running to osteoarthritis of the knee and hip and bone mineral density of the lumbar spine: a 9 year longitudinal study. (1998) (135)
The PROMIS of Better Outcome Assessment: Responsiveness, Floor and Ceiling Effects, and Internet Administration (2011) (134)
Systemic lupus erythematosus: a clinical analysis. (1975) (133)
The assessment of disability: from first to future principles. (1983) (127)
Responsiveness and minimally important difference for the patient-reported outcomes measurement information system (PROMIS) 20-item physical functioning short form in a prospective observational study of rheumatoid arthritis. (2015) (125)
Reducing disability in older age. (2002) (124)
From experiment to experience: side effects of nonsteroidal anti-inflammatory drugs. (1983) (123)
An "experimental" epidemic of Reiter's syndrome revisited. Follow-up evidence on genetic and environmental factors. (1976) (123)
The dimensions of health outcomes: a cross-validated examination of health status measurement. (1984) (121)
Postponed development of disability in elderly runners: a 13-year longitudinal study. (2002) (121)
Mortality predictors among 263 patients with rheumatoid arthritis. (1991) (120)
Reduction in long-term functional disability in rheumatoid arthritis from 1977 to 1998:a longitudinal study of 3035 patients. (2003) (119)
Equipoise, design bias, and randomized controlled trials: the elusive ethics of new drug development (2004) (118)
Physical Activity, the Compression of Morbidity, and the Health of the Elderly (1996) (117)
Compression of morbidity in the elderly. (2000) (116)
The rise and decline of nonsteroidal antiinflammatory drug-associated gastropathy in rheumatoid arthritis. (2004) (116)
Criteria for rheumatic disease. Different types and different functions. The American College of Rheumatology Diagnostic and Therapeutic Criteria Committee. (1994) (115)
Time-oriented patient records and a computer databank. (1972) (115)
Patient education and health promotion can be effective in Parkinson's disease: A randomized controlled trial (1994) (115)
Vitality and Aging: Implications of the Rectangular Curve (1981) (115)
Aging, long-distance running, and the development of musculoskeletal disability. A controlled study. (1987) (109)
Aspirin, hydroxychloroquine, and hepatic enzyme abnormalities with methotrexate in rheumatoid arthritis. (1990) (104)
Propensity-adjusted association of methotrexate with overall survival in rheumatoid arthritis. (2013) (103)
Lifestyle risk factors predict disability and death in healthy aging adults. (2012) (102)
Randomized Controlled Trial of Cost Reductions from a Health Education Program: The California Public Employees' Retirement System (PERS) Study (1994) (99)
TOXIC EFFECTS OF AZATHIOPRINE IN RHEUMATOID ARTHRITIS: A National Post‐Marketing Perspective (1989) (99)
Prevalence and expression of photosensitivity in systemic lupus erythematosus. (1989) (97)
Better assessment of physical function: item improvement is neglected but essential (2009) (97)
Upper-extremity and mobility subdomains from the Patient-Reported Outcomes Measurement Information System (PROMIS) adult physical functioning item bank. (2013) (97)
Scleroderma-like lesions and the carcinoid syndrome. (1973) (96)
HLA-DRB1 genotype associations in 793 white patients from a rheumatoid arthritis inception cohort: frequency, severity, and treatment bias. (2002) (96)
Aging, natural death, and the compression of morbidity. 1980. (2002) (95)
Quality of life and health service use among HIV-infected patients with chronic diarrhea. (1993) (94)
Assessment of quality of life in early stage HIV-infected persons: data from the AIDS Time- Oriented Health Outcome Study (ATHOS) (1997) (93)
Randomized Controlled Study of a Retiree Health Promotion Program The Bank of America Study (1992) (92)
Adrenocortical steroid treatment of rheumatic diseases. Effects on lipid metabolism. (1973) (91)
Gastrointestinal toxicity of nonsteroidal antiinflammatory drugs. (1999) (91)
Weight-bearing exercise, overexercise, and lumbar bone density over age 50 years. (1989) (90)
Health status disparities in ethnic minority patients with rheumatoid arthritis: a cross-sectional study. (2007) (90)
Aging, Illness, and Health Policy: Implications of the Compression of Morbidity (2015) (89)
Impact of running on lumbar bone density: a 5-year longitudinal study. (1992) (89)
A Canadian study of the total medical costs for patients with systemic lupus erythematosus and the predictors of costs. (1993) (89)
Alternatives in Medical Record Formats (1974) (88)
A toxicity index for comparison of side effects among different drugs. (1990) (86)
Predictors of disability in a longitudinal sample of patients with rheumatoid arthritis. (1992) (86)
Frailty, heart disease, and stroke: the Compression of Morbidity paradigm. (2005) (85)
Associations of changes in exercise level with subsequent disability among seniors: a 16-year longitudinal study. (2006) (84)
The compression of morbidity: miscellaneous comments about a theme. (1984) (84)
Variables associated with decreased survival in systemic lupus erythematosus. (1991) (82)
Disability in rheumatoid arthritis: comparison of prognostic factors across three populations. (1987) (81)
Nonsteroidal anti-inflammatory agents in rheumatoid arthritis and ankylosing spondylitis. (1981) (80)
Cardiovascular risk profile earlier in life and Medicare costs in the last year of life. (2005) (80)
Estimating prognosis in systemic lupus erythematosus. (1974) (79)
Health status among persons infected with human immunodeficiency virus. A community-based study. (1993) (79)
Trends in antirheumatic medication use among patients with rheumatoid arthritis, 1981-1996. (1998) (78)
Seasonal variation in the onset of Wegener's granulomatosis, polyarteritis nodosa and giant cell arteritis. (1993) (76)
"Arthritis specific" global health analog scales assess "generic" health related quality-of-life in patients with rheumatoid arthritis. (1997) (75)
Standardizing Assessment and Reporting of Adverse Effects in Rheumatology Clinical Trials II: the Rheumatology Common Toxicity Criteria v.2.0 (2007) (75)
Improving patient reported outcomes using item response theory and computerized adaptive testing. (2007) (74)
Disability in rheumatoid arthritis in the era of biological treatments (2011) (73)
Asymptomatic hyperuricemia: the case for conservative management. (1978) (71)
A multicenter study of hospitalization in rheumatoid arthritis. Frequency, medical-surgical admissions, and charges. (1986) (71)
Cyclophosphamide therapy in systemic lupus erythematosus and polymyositis. (1973) (70)
Health habits, health care use and costs in a sample of retirees. (1992) (70)
The relationship between spinal and peripheral osteoarthritis and bone density measurements. (1993) (69)
Late-stage lupus nephropathy. (1974) (68)
The influence of systemic lupus erythematosus on fetal development: Cognitive, behavioral, and health trends (1997) (66)
Running, osteoarthritis, and bone density: initial 2-year longitudinal study. (1990) (65)
A modular self-describing clinical databank system. (1975) (65)
Aerobic exercise and its impact on musculoskeletal pain in older adults: a 14 year prospective, longitudinal study (2005) (65)
Successful aging--an emerging paradigm of gerontology. (2002) (64)
Current treatment paradigms in rheumatoid arthritis. (2000) (63)
Medical perspectives upon successful aging (1990) (63)
ARAMIS (the American Rheumatism Association Medical Information System). A prototypical national chronic-disease data bank. (1986) (61)
Marginal benefit of renal biopsy in systemic lupus erythematosus. (1978) (60)
Predisposing factors in polymyositis-dermatomyositis: results of a nationwide survey. (1989) (60)
Rates of serious gastrointestinal events from low dose use of acetylsalicylic acid, acetaminophen, and ibuprofen in patients with osteoarthritis and rheumatoid arthritis. (2003) (60)
Identification of patients at risk for gastropathy associated with NSAID use. (1990) (60)
Comparative toxicity of non-steroidal anti-inflammatory agents. (1994) (60)
Establishing a Common Metric for Physical Function: Linking the HAQ-DI and SF-36 PF Subscale to PROMIS® Physical Function (2015) (59)
Testing the 'preliminary criteria for classification of SLE'. (1973) (59)
Successful medical treatment of scleroderma renal crisis. (1978) (59)
Health Risk Changes with a Low-Cost Individualized Health Promotion Program: Effects at up to 30 Months (1992) (58)
The hierarchy of quality-of-life assessment, the Health Assessment Questionnaire (HAQ), and issues mandating development of a toxicity index. (1991) (57)
Longitudinal comparison of the Health Assessment Questionnaire (HAQ) and the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC). (2004) (56)
Cancer in rheumatoid arthritis: a prospective long-term study of mortality. (1985) (56)
Percentile benchmarks in patients with rheumatoid arthritis: Health Assessment Questionnaire as a quality indicator (QI) (2004) (55)
Changes in quality of life among persons with HIV infection (1992) (53)
Toward an understanding of NSAID-related adverse events: the contribution of longitudinal data. (1996) (52)
Take Care of Yourself (1976) (51)
The sunny side of aging. (1990) (50)
Reducing need and demand for medical services in high-risk persons. A health education approach. (1998) (50)
Severity of disability and duration of disease in rheumatoid arthritis. (1992) (49)
Assessing and understanding patient risk. (1992) (48)
More relevant, precise, and efficient items for assessment of physical function and disability: moving beyond the classic instruments (2006) (48)
Development and assessment of floor and ceiling items for the PROMIS physical function item bank (2013) (47)
Predictors of physical disability after age 50. Six-year longitudinal study in a runners club and a university population. (1994) (47)
Occupation, income, and education as independent covariates of arthritis in four national probability samples. (1991) (47)
The Theory and Practice of Active Aging (2012) (46)
An analysis of the American Rheumatism Association criteria for rheumatoid arthritis. (1982) (46)
Impact of specific therapy upon rheumatoid arthritis. (1986) (44)
A Data Bank for the Clinician (1976) (43)
Gender and race differences in the correlation between body mass and education in the 1971-1975 NHANES I. (1992) (43)
Regular vigorous physical activity and disability development in healthy overweight and normal-weight seniors: a 13-year study. (2008) (41)
The Arthritis, Rheumatism and Aging Medical Information System (ARAMIS): still young at 30 years. (2005) (41)
Osteoarthritis in the hand: a comparison of handedness and hand use. (1989) (41)
Strategies for reduction of morbidity. (1992) (40)
A multicenter study of hospitalization in rheumatoid arthritis: effect of health care system, severity, and regional difference. (1986) (40)
A reevaluation of aspirin therapy in rheumatoid arthritis. (1993) (40)
Risk factors for adult Still's disease. (1996) (40)
Education, Gender, and the Compression of Morbidity (1994) (38)
Take Care of Yourself: A Consumer's Guide to Medical Care (1976) (36)
Prednisone Use and Risk of Mortality in Patients With Rheumatoid Arthritis: Moderation by Use of Disease‐Modifying Antirheumatic Drugs (2016) (36)
TOD: A Software System for the Aramis Data Bank (1979) (35)
Correlations between education and arthritis in the 1971-1975 NHANES I. (1994) (34)
Primary knee and hip arthroplasty among nonagenarians and centenarians in the United States. (2007) (34)
Irreversible bone marrow failure with chlorambucil. (1975) (34)
Favorable Cardiovascular Health, Compression of Morbidity, and Healthcare Costs: Forty-Year Follow-Up of the CHA Study (Chicago Heart Association Detection Project in Industry). (2017) (33)
Relationship of running to musculoskeletal pain with age. A six-year longitudinal study. (1996) (33)
Why health care costs more in the US: comparing health care expenditures between systemic lupus erythematosus patients in Stanford and Montreal. (1996) (32)
The chronic disease data bank: first principles to future directions. (1984) (32)
Methotrexate, hydroxychloroquine, and intramuscular gold in rheumatoid arthritis: relative area under the curve effectiveness and sequence effects. (2002) (32)
Patient Perspective Workshop: Moving Towards OMERACT Guidelines for Choosing or Developing Instruments to Measure Patient-Reported Outcomes (2011) (30)
Aging, cumulative disability, and the compression of morbidity (2001) (30)
Attrition bias in rheumatoid arthritis databanks: a case study of 6346 patients in 11 databanks and 65,649 administrations of the Health Assessment Questionnaire. (2004) (29)
Education level and rheumatoid arthritis: evidence from five data centers. (1991) (29)
Measuring effectiveness of drugs in observational databanks: promises and perils (2004) (29)
Disability in occupations in a national sample. (1992) (29)
The methotrexate therapeutic response in rheumatoid arthritis. (2002) (29)
Effect of changes in weight-bearing exercise on lumbar bone mass after age fifty. (1991) (28)
Patient education and health promotion can be effective in Parkinson's disease: a randomized controlled trial. PROPATH Advisory Board. (1994) (28)
Reducing attrition bias with an instrumental variable in a regression model: results from a panel of rheumatoid arthritis patients. (1993) (28)
Arthritis and mortality in the epidemiological follow-up to the National Health and Nutrition Examination Survey I. (1994) (28)
Sulfonamide hepatitis. Report of a case due to sulfamethoxazole and sulfisoxazole. (1966) (27)
Time-related issues with application to health gains and losses. (2002) (27)
Disability outcomes and dose escalation with etanercept, adalimumab, and infliximab in rheumatoid arthritis patients: a US-based retrospective comparative effectiveness study (2012) (27)
Fenoprofen calcium in rheumatoid arthritis. A controlled double-blind crossover evaluation. (1973) (26)
A first step to assess harm and benefit in clinical trials in one scale. (2010) (26)
Patient Perspective: Choosing or Developing Instruments (2011) (26)
A uniform database for rheumatic diseases. (1979) (26)
Reduced Disability and Mortality Among Aging Runners (2008) (25)
The chronic disease data bank model: a conceptual framework for the computer-based medical record. (1992) (25)
Can preventive gerontology be on the way? (1997) (24)
Disease criteria for systemic lupus erythematosus. (1984) (24)
Items, Instruments, Crosswalks, and PROMIS (2009) (23)
The relative toxicity of alternative therapies for rheumatoid arthritis: implications for the therapeutic progression. (1993) (23)
The compression of morbidity. (1983) (23)
Physiologic Studies in Systemic Sclerosis (Scleroderma) (1969) (23)
Immunity to Injectable Collagen and Autoimmune Disease: A Summary of Current Understanding (1988) (23)
Effectiveness and toxicity considerations in outcome directed therapy in rheumatoid arthritis. (1996) (23)
Framing health messages based on anomalies in time preference. (2005) (23)
A standard database for rheumatic diseases. (1974) (23)
Extending the Floor and the Ceiling for Assessment of Physical Function (2014) (23)
Changes in health status after one year for persons at-risk for and with HIV infection (1994) (22)
Factors influencing length of time taking methotrexate in rheumatoid arthritis. (2000) (22)
Associations among Healthy Habits, Age, Gender, and Education in a Sample of Retirees (1993) (22)
Powering our way to the elusive side effect: a composite outcome 'basket' of predefined designated endpoints in each organ system should be included in all controlled trials. (2005) (22)
Usefulness of the HAQ in the clinic (2001) (21)
Hours at work and employment status among HIV‐infected patients (1995) (20)
The ARAMIS (American Rheumatism Association Medical Information System) Post-Marketing Surveillance Program (1985) (20)
ARAMIS: A National Chronic Disease Data Bank System (1979) (20)
Methodology of validation of criteria for SLE. (1987) (20)
Advances in management of rheumatic disease. 1965 to 1985. (1989) (20)
Lymphoma and Luekemia in Rheumatoid Arthritis: Are They Associated with Azathioprine, Cyclophosphamide, or Methotrexate? (1996) (20)
Response to therapy in rheumatoid arthritis is influenced by immediately prior therapy. (1997) (19)
Comparative risks of non-prescription analgesics: a structured topic review and research priorities (2012) (19)
Health status instruments / utilities. (1995) (19)
Joint pain or arthritis. (1976) (19)
Modeling therapeutic strategies in rheumatoid arthritis: use of decision analysis and Markov models. (2000) (19)
Favorable Cardiovascular Health, Compression of Morbidity, and Healthcare CostsClinical Perspective (2017) (19)
Photopheresis for scleroderma? No! (1992) (18)
Hierarchical time-oriented approaches to missing data inference. (1988) (18)
A patient-administered questionnaire for arthritis assessment. (1978) (18)
Intra-arterially administered reserpine and saline in scleroderma. (1974) (18)
The natural history of ankylosing spondylitis: is the disease really changing? (1989) (18)
The clinical aspects of systemic lupus erythematosus. (1977) (17)
Exercise and the Health of the Elderly. (1997) (17)
Science as experiment; science as observation (2006) (16)
Reducing the need and demand for medical services. (1998) (16)
Simultaneous vasculitis in a mother and newborn infant. (1975) (16)
Safety, cost and effectiveness issues with disease modifying anti-rheumatic drugs in rheumatoid arthritis (1999) (16)
Reducing the Need and Demand for Medical Care: Implications for Quality Management and Outcome Improvement (1997) (16)
Standardized assessment of adverse events in rheumatology clinical trials: summary of the OMERACT 7 drug safety module update. (2005) (16)
Prevention of osteoporotic fractures: possibilities, the role of exercise, and limitations. (1996) (16)
Reciprocal skin grafts in systemic sclerosis (scleroderma). (1971) (16)
A controlled trial of antihypertensive therapy in systemic sclerosis (scleroderma). (1984) (16)
Rate of death due to leukemia/lymphoma in patients with rheumatoid arthritis. (2003) (15)
Potential and actual workdays lost among patients with HIV. (1995) (15)
What constitutes progress in assessing patient outcomes? (2009) (15)
The close correlation between symptoms and disease expression in HLA B27 positive individuals. (1977) (15)
The Arthritis Helpbook: A Tested Self-Management Program for Coping With Your Arthritis (1986) (15)
Randomized controlled study of a retiree health promotion program. The Bank of American Study. (1992) (14)
ARAMIS and toxicity measurement. (Arthritis Rheumatism and Aging Medical Information System). (1995) (14)
Part 2: Treatment Approaches (2015) (14)
Plain radiographs can be useful in estimating lumbar bone density. (1990) (14)
The future of disease and treatment. Changing health conditions, changing behaviors, and new medical technology. (1986) (13)
Prognosis: Contemporary Outcomes of Disease (1981) (13)
A "state model" of renal function in systemic lupus erythematosus: its value in the prediction of outcome in 292 patients. (1989) (13)
The epidemiology of NSAID gastropathy: the ARAMIS experience. (1998) (13)
Compression of morbidity 1993: life span, disability, and health care costs (1993) (13)
New instruments for assessing disability: not quite ready for prime time. (2004) (13)
Experience counting in sequential computer diagnosis. (1970) (13)
Favorable Cardiovascular Health at Young and Middle Ages and Dementia in Older Age—The CHA Study (2018) (12)
How may quality of life for rheumatoid arthritis patients be enhanced by current and future treatments? (1999) (12)
Quality-of-life considerations with respect to arthritis and nonsteroidal anti-inflammatory drugs. (1998) (12)
Postmarketing drug surveillance: are our priorities right? (1988) (12)
Suggested guidelines for monitoring liver toxicity in rheumatoid arthritis patients treated with methotrexate: comment on the article by Kremer et al. (1994) (12)
The present and future of comprehensive outcome measures for rheumatic diseases (1987) (12)
The variability of immunologic laboratory tests. (1982) (12)
Discounting and risk characteristics in clinical decision-making. (2006) (11)
Safety issues related to DMARD therapy. (1990) (11)
Health status instruments and physical examination techniques in clinical measurement methodologies (1992) (11)
Containing costs in chronic disease: monitoring strategies in the gold therapy of rheumatoid arthritis. (1978) (11)
Patient self-management in arthritis? Yes! (2003) (11)
The hierarchy of outcome assessment. (1993) (11)
Postmarketing surveillance in rheumatology: analysis of purpura and upper abdominal pain. (1988) (11)
Challenges and progress in adverse event ascertainment and reporting in clinical trials. (2005) (11)
Epidemiology of cancer in rheumatoid arthritis: methodologic pitfalls. (1985) (11)
Health Assessment Questionnaire (2012) (10)
Varying the item format improved the range of measurement in patient-reported outcome measures assessing physical function (2017) (10)
Absenteeism and HIV infection (1997) (10)
Ankylosing spondylitis: Discussions in patient management (1978) (10)
Unilateral ptosis as an initial manifestation of D-penicillamine induced myasthenia gravis. (1993) (10)
Osteophytosis of the knee: Association with changes in weight-bearing exercise (1992) (10)
Comparative toxicity of total lymphoid irradiation and immunosuppressive drug treated patients with intractable rheumatoid arthritis. (1987) (9)
Platonic outcomes. (1993) (9)
How to Ascertain Drug Safety in the Context of Benefit. Controversies and Concerns (2009) (9)
Time-oriented functional profile: practical applications in a stroke data-base model. (1979) (9)
Arthritis: A Comprehensive Guide (1979) (9)
The microvascular pathogenesis of scleroderma: an hypothesis. (1979) (9)
Abstract 31: Cardiovascular Health at Young and Middle Ages and Dementia in Older Age - The Chicago Heart Association Detection Project in Industry Study (2017) (9)
Treatment decisions in systemic lupus erythematosus. (1980) (8)
Reducing cumulative lifetime disability: the compression of morbidity. (1998) (8)
Famotidine to prevent peptic ulcer caused by NSAIDs. (1996) (8)
Patient based method of assessing adverse events in clinical trials in rheumatology: the revised Stanford Toxicity Index. (2001) (8)
Education for outcome. (1978) (8)
The Potential Perils of Informed Consent (2008) (8)
Letter: Normal frequency of HL-A B27 in aortic insufficiency. (1976) (7)
Comparison of therapy in severe systemic lupus erythematosus employing stratification techniques. (1978) (7)
Physical activity and fractures over the age of fifty years (2004) (7)
On the Compression of Morbidity: From 1980 to 2015 and Beyond (2016) (7)
Tobit, fixed effects, and cohort analyses of the relationship between severity and duration of rheumatoid arthritis. (1993) (6)
Arthritis A Comprehensive Guide to Understanding Your Arthritis (1986) (6)
Cardiovascular health in young and middle adulthood and medical care utilization and costs at older age - The Chicago Heart Association Detection Project Industry (CHA). (2019) (6)
ARAMIS today: Moving toward internationally distributed databank systems for follow-up studies (1987) (6)
Taking Care of Your Child: A Parent's Illustrated Guide to Complete Medical Care (1977) (6)
Prophylaxis of nonsteroidal antiinflammatory drug gastropathy: a clinical opinion. (1991) (6)
Aging Well: A Guide for Successful Seniors (1989) (5)
Factors in the duration and discontinuation of treatment with nonsteroidal anti-inflammation medications (1991) (5)
Relationship of running to osteoarthritis and bone density. (1988) (5)
Minimally Important Differences for Patient-Reported Outcomes Measurement Information System (Promis) Fatigue and Pain Interference Scores (2015) (5)
Mortality in rheumatoid arthritis patients (1999) (5)
Ankylosing spondylitis and epidemic Reiter's syndrome: genetics and environment [Proceedings]. (1976) (5)
Aging, Frailty, and the Compression of Morbidity: Definite Progress (2005) (5)
Rheumatoid arthritis: radiographic progression is getting milder. (2005) (5)
The promise of the future, updated: better outcome tools, greater relevance, more efficient study, lower research costs (2006) (5)
Selective cyclooxygenase inhibition: promise for future NSAID therapy? (1996) (4)
A low tension between individual and societal time aspects in health improved outcomes. (2006) (4)
PMS2 DISABILITY OUTCOMES AND DOSE ESCALATION IN RHEUMATOID ARTHRITIS PATIENTS TREATED WITH TUMOR NECROSIS FACTOR BLOCKERS: A COMPARATIVE EFFECTIVENESS ANALYSIS (2010) (4)
Autoimmune Disease and Collagen Dermal Implants (1994) (4)
Detecting treatment effects in patients with rheumatoid arthritis: the advantage of longitudinal data. (1993) (4)
Frailty and education in the Hispanic Health and Nutrition Examination Survey. (2002) (4)
Effect of self-care book. (1981) (4)
The chronic disease data bank-the ARAMIS experience (1988) (3)
Can liver test abnormalities in patients with rheumatoid arthritis be predicted by clinical symptoms? (1992) (3)
Frailty and Education in the Hispanic Health and Nutrition Examination Survey (2002) (3)
On the reassessment of the prevalence of As among B27 positive normal individuals. (1980) (3)
Perspectives From Masters in Rheumatology and Autoimmunity: Perspectives on the Conventional Wisdom (2015) (3)
THE PROCESS OF RECTANGULARIZATION OF THE SURVIVAL CURVE IN SELECTED EASTERN EUROPEAN COUNTRIES (2009) (3)
Comparison of the health assessment questionnaire disability index and the short form 36 physical functioning subscale using Rasch analysis: comment on the article by Taylor and McPherson. (2008) (3)
Health care demand management. (1994) (3)
Improvement in intergenerational health. (1992) (3)
Editorial: A data bank for the clinician? (1976) (2)
Can prevention lower health costs by reducing demand? Yes. (1994) (2)
Reducing need and demand. (1993) (2)
Postponed Development of Disability in Elderly Runners (2017) (2)
Osteoarthritis, Exercise, and Knee Replacement (2012) (2)
Measuring the quality of life in relation to arthritis therapy. (1983) (2)
The single hot joint. (1976) (2)
MORTALITY IN RHEUMATOID ARTHRITIS PATIENTS. AUTHORS' REPLY (1999) (2)
Rheumatologist Perceptions of Sources of Health Care Disparities in Minority Rheumatoid Arthritis Patients (2009) (2)
Robine and Michel's "Looking forward to a general theory on population aging": commentary. (2004) (2)
Letter: HL-A antigens and ankylosing spondylitis. (1975) (1)
Outcome Assessment in the Rheumatic Diseases (1989) (1)
The declining incidence of nonsteroidal anti-inflammatory drug gastropathy in rheumatoid arthritis patients: rates and reasons (2003) (1)
Life expectancy increases, but the life span is fixed. (1982) (1)
Some problems in the interpretation of clinical trials: longterm parallel study of fenoprofen in rheumatoid arthritis. (1976) (1)
Effects of Regular Walking on Mortality among Nonsmoking Retired Men (1998) (1)
Effects of new 1993 criteria for classification of AIDS. (1993) (1)
The relation of running to bone and joint disease. (1986) (1)
Abstract 18634: Favorable Cardiovascular Health and the Compression of Morbidity: Findings From the Chicago Heart Detection Project in Industry Study (2015) (1)
Serum urate levels. (1972) (1)
Osteoarthritis : New Insights Part 2 : Treatment Approaches Conference (2000) (1)
The irreversible component of the disability index of the health assessment questionnaire: comment on the article by Aletaha et al. (2007) (1)
Ankylosing Spondylitis-Reply (1977) (1)
Health promotion and the compression of morbidity 308 (1994) (1)
On Running Late In Life. Authors' reply (2009) (1)
LUNG CANCER. DETECTION BY USE OF ELECTRICAL SKIN RESISTANCE METHOD. (1964) (1)
Ankylosing spondylitis: genetics versus environment. (1976) (1)
Living Well: Taking Care Of Your Health In The Middle And Later Years (1993) (1)
Patient Education and Health Promotion Can Be in Parkinson's Disease: A Randomized Controlled (1994) (1)
Cardiovascular Health , Compression of Morbidity , and Healthcare Costs Forty-Year Follow-Up of the CHA Study (2017) (0)
Proceedings of the Second Update on Psoriatic Disease, University Federico II Congress Center, July 6–7, 2011, Naples, Italy. (2012) (0)
Reducing cumulative lifetime disability: the compression of (1998) (0)
Self-care algorithms. (1979) (0)
Author Reply to Commentary (1992) (0)
Abstract 20310: Excess All-Cause and Cardiovascular Morbidity Associated With Overweight and Obesity: Findings From the Chicago Heart Detection Project in Industry Study (2016) (0)
Child Health Assessment Questionnaire (2020) (0)
WORKSHOP REPORT - HEALTH-STATUS INSTRUMENTS UTILITIES (1995) (0)
On Running Late in Life—Reply (2009) (0)
Book Review Cheating Time: Science, sex, and aging By Roger Gosden. 427 pp., illustrated. New York, W.H. Freeman, 1996. $23.95. 0-7167-3059-6 (1997) (0)
Patient-Reported Outcomes Measurement Information System Physical Function Item Bank (2020) (0)
The Compression of Morbidity paradigm emphasizes reduction in cumulative disability by postponing chronic infirmity (0)
Take care of yourself: Your personal guide to self-care & preventing illness (1990) (0)
Intraluminal esophageal rewarming in normals and in patients with connective tissue disease. (1974) (0)
and the Future of Medicare Costs (2004) (0)
Prevention: Environmental Factors and Behavior (1996) (0)
Longterm survival after renal crisis. (1990) (0)
The epidemiology of systemic lupus erythematosus: 1950–1990 conceptual advances and the ARAMIS data banks (1990) (0)
Abstracts (2009) (0)
moving beyond the classic instruments assessment of physical function and disability: More relevant, precise, and efficient items for (2006) (0)
Abstract P155: Cardiovascular Health at Young and Middle Ages and Medical Care Costs at Old Age (2017) (0)
Exercise for Degenerative Arthritis of the Spine (1993) (0)
Systemic corticosteroid therapy in rheumatic diseases. (1972) (0)
The biological constraints on human aging: implications for health policy. (2008) (0)
Perspectives on the conventional wisdom (2015) (0)
In defense of the ARA database. (1977) (0)
Health Assessment Questionnaire (HAQ) Disability Section 1980 (1996) (0)
cytokines associated with up regulation of proinflammatory rheumatoid arthritis : anti-citrulline autoreactivity is Proteomic analysis of secreted proteins in early (2007) (0)
More on scleroderma renal crisis. (1998) (0)
The approach to the rheumatic disease patient. (1979) (0)
cytokineswith up regulation of proinflammatory rheumatoid arthritis: anti-citrulline autoreactivity is Proteomic analysis of secreted proteins in early (2007) (0)
Health Assessment Questionnaire (HAQ) 1980 (1996) (0)
Health Affairs medical care Beyond health promotion : reducing need and demand for (2001) (0)
THE COOL PATELLA SIGN . REPLY (1992) (0)
Better medical care: prevention, recognition, and action. (1977) (0)
Predictors ofdisability ina longitudinal sample of patients withrheumatoid arthritis (2011) (0)
Rheumatoid arthritis: Radiographic progression is getting milder. Authors' reply (2005) (0)
Simultaneous infant vasculitis in a mother and newborn (1975) (0)
Increase in bone density in osteoarthritis patients (1993) (0)
1971-1975 NHANES I . between body mass and education in the Gender and race differences in the correlation (0)
A new sign (Fries' knees) for early detection of inflammation of the knee joint. (1990) (0)
Comparative toxicity of nonsteroidal anti-inflammatory drugs. Discussion (1999) (0)
Glucocorticoids and joint destruction in rheumatoid arthritis. (1995) (0)
Abstract MP22: Cardiovascular Health in Young Adulthood and Middle Age is Associated with Cumulative Burden of Morbidity in Older Age (2015) (0)
Erratum: Errors in Tables 1 and 2 in Article by Krishnan et al (Arthritis Rheum August 2007) (2011) (0)
lupus erythematosus . photosensitivity in systemic Prevalence and expression of (2004) (0)
Abstract 120: Persistence in Antihypertensive Therapy - The Chicago Heart Association Detection Project Industry Study (2018) (0)
Estimating lumbar bone mineral density from routine radiographs of the lumbar spine (1993) (0)
Robert B. Wallace and Robert F. Woolson (eds), The Epidemiologic Study of the Elderly , Oxford University Press, New York, 1992, 387 pp., £60.00, ISBN 0 195 06120 9. (1993) (0)
Pharmacology and efficacy of cyclooxygenase (COX) inhibitors. Discussion (1999) (0)

This paper list is powered by the following services:

Other Resources About James F. Fries

en.wikipedia.org

What Schools Are Affiliated With James F. Fries?

James F. Fries is affiliated with the following schools:

James F. Fries's Academic­Influence.com Rankings